Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 152.10
-11.80 (-7.20%)
Jun 4, 2026, 1:27 PM IDT
Evogene Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.77 | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 |
Depreciation & Amortization | 1.04 | 1.14 | 1.38 | 1.3 | 2.58 | 2.23 |
Other Amortization | 2.71 | 1.32 | 0.47 | - | - | - |
Loss (Gain) From Sale of Assets | -0.04 | -0.21 | 0.53 | -0.03 | - | 0.12 |
Asset Writedown & Restructuring Costs | 0.25 | 0.25 | - | - | - | - |
Loss (Gain) on Equity Investments | 0.08 | 0.04 | 0.04 | - | - | - |
Stock-Based Compensation | 0.41 | 0.65 | 1.24 | 1.11 | 1.19 | 2.61 |
Other Operating Activities | -3.23 | -4.85 | -2.08 | 2.23 | -0.04 | -3.54 |
Change in Accounts Receivable | 2.23 | 0.67 | -0.63 | -0.01 | -0.07 | -0.06 |
Change in Inventory | -0.54 | -1.02 | -1.28 | 0.49 | -0.47 | -0.09 |
Change in Accounts Payable | -0.07 | -0.26 | -0.63 | 0.76 | -0.47 | 0.63 |
Change in Unearned Revenue | -0.21 | -0.36 | -0.56 | -0.29 | -0.15 | 0.13 |
Change in Other Net Operating Assets | -1.02 | -0.28 | 0.48 | -1.23 | 0.49 | 1.05 |
Operating Cash Flow | -11.27 | -13.5 | -19.7 | -21.58 | -23.68 | -24.72 |
Capital Expenditures | -0.02 | -0.14 | -0.63 | -0.58 | -1.17 | -0.85 |
Sale of Property, Plant & Equipment | 0.1 | 0.08 | 0.01 | 0.03 | - | - |
Investment in Securities | -2.2 | -0 | 10.19 | -3.78 | 14.45 | -19.72 |
Other Investing Activities | 17.81 | 17.8 | 0.05 | -0.21 | - | - |
Investing Cash Flow | 15.7 | 17.74 | 9.62 | -4.54 | 13.27 | -20.57 |
Long-Term Debt Repaid | - | -0.53 | -0.89 | -0.68 | -0.8 | -0.58 |
Net Debt Issued (Repaid) | -0.5 | -0.53 | -0.89 | -0.68 | -0.8 | -0.58 |
Issuance of Common Stock | 7.49 | 4.28 | 5.62 | 8.45 | 0.03 | 30.07 |
Other Financing Activities | -10.44 | -10.36 | -0.08 | 10.38 | 10.12 | 0.79 |
Financing Cash Flow | -3.45 | -6.6 | 4.66 | 18.15 | 9.34 | 30.28 |
Foreign Exchange Rate Adjustments | 0.04 | 0.02 | -0.05 | -0.25 | -2.28 | 1.1 |
Net Cash Flow | 1.02 | -2.35 | -5.47 | -8.21 | -3.35 | -13.9 |
Free Cash Flow | -11.29 | -13.64 | -20.33 | -22.15 | -24.85 | -25.56 |
Free Cash Flow Margin | -612.26% | -353.93% | -364.46% | -742.92% | -1483.52% | -2748.71% |
Free Cash Flow Per Share | -1.31 | -1.73 | -3.57 | -4.83 | -6.00 | -6.32 |
Cash Interest Paid | 0.19 | 0.19 | 0.07 | 0.12 | 0.17 | 0.32 |
Cash Income Tax Paid | 0.03 | 0.01 | 0.01 | 0.03 | 0.04 | 0.01 |
Levered Free Cash Flow | -12.2 | -17.49 | 0.13 | -11.79 | -14.89 | -17.97 |
Unlevered Free Cash Flow | -9.93 | -17.4 | 0.17 | -11.72 | -14.78 | -17.77 |
Change in Working Capital | 0.4 | -1.25 | -2.61 | -0.28 | -0.77 | 1.66 |